209 related articles for article (PubMed ID: 6842402)
21. Gastric cytoprotective effect of morphine is probably not mediated by mu-receptors.
Bhounsule SA; D'Souza RS; Dhume VG
Arch Int Pharmacodyn Ther; 1994; 328(1):99-105. PubMed ID: 7893194
[TBL] [Abstract][Full Text] [Related]
22. Discriminative stimulus effects of butorphanol: influence of training dose on the substitution patterns produced by Mu, Kappa and Delta opioid agonists.
Picker MJ; Benyas S; Horwitz JA; Thompson K; Mathewson C; Smith MA
J Pharmacol Exp Ther; 1996 Dec; 279(3):1130-41. PubMed ID: 8968334
[TBL] [Abstract][Full Text] [Related]
23. Buprenorphine, morphine and naloxone effects during ascending morphine maintenance in humans.
Schuh KJ; Walsh SL; Bigelow GE; Preston KL; Stitzer ML
J Pharmacol Exp Ther; 1996 Aug; 278(2):836-46. PubMed ID: 8768738
[TBL] [Abstract][Full Text] [Related]
24. Effects of opioids on accuracy of a fixed-ratio discrimination in monkeys and rats.
Moerschbaecher JM; Mastropaolo J; Winsauer PJ; Thompson DM
J Pharmacol Exp Ther; 1984 Sep; 230(3):541-9. PubMed ID: 6381692
[TBL] [Abstract][Full Text] [Related]
25. Acute effects of pentazocine, naloxone and morphine in opioid-dependent volunteers.
Lamas X; Farre M; Cami J
J Pharmacol Exp Ther; 1994 Mar; 268(3):1485-92. PubMed ID: 8138958
[TBL] [Abstract][Full Text] [Related]
26. Enhancement mu opioid antinociception by oral delta9-tetrahydrocannabinol: dose-response analysis and receptor identification.
Cichewicz DL; Martin ZL; Smith FL; Welch SP
J Pharmacol Exp Ther; 1999 May; 289(2):859-67. PubMed ID: 10215664
[TBL] [Abstract][Full Text] [Related]
27. Differential effects of prototype opioid agonists on the acquisition of conditional discriminations in monkeys.
Moerschbaecher JM; Thompson DM
J Pharmacol Exp Ther; 1983 Sep; 226(3):738-48. PubMed ID: 6887010
[TBL] [Abstract][Full Text] [Related]
28. Body temperature and analgesic effects of selective mu and kappa opioid receptor agonists microdialyzed into rat brain.
Xin L; Geller EB; Adler MW
J Pharmacol Exp Ther; 1997 Apr; 281(1):499-507. PubMed ID: 9103537
[TBL] [Abstract][Full Text] [Related]
29. Single-dose tolerance to morphine hypothermia in the rat: differentiation of acute from long-term tolerance.
Rosenfeld GC; Burks TF
J Pharmacol Exp Ther; 1977 Sep; 202(3):654-9. PubMed ID: 197229
[TBL] [Abstract][Full Text] [Related]
30. Morphine, opioids, and the feline pulmonary vascular bed.
Kaye AD; Hoover JM; Kaye AJ; Ibrahim IN; Fox C; Bajwa A; Anwar M; Fields AM; Baluch A; Huffman S; Chilian W
Acta Anaesthesiol Scand; 2008 Aug; 52(7):931-7. PubMed ID: 18477088
[TBL] [Abstract][Full Text] [Related]
31. Measuring naloxone antagonism of discriminative opioid stimulus.
Krimmer EC; Barry H
Fed Proc; 1982 May; 41(7):2319-22. PubMed ID: 7042395
[TBL] [Abstract][Full Text] [Related]
32. Assessment of opioid partial agonist activity with a three-choice hydromorphone dose-discrimination procedure.
Jones HE; Bigelow GE; Preston KL
J Pharmacol Exp Ther; 1999 Jun; 289(3):1350-61. PubMed ID: 10336526
[TBL] [Abstract][Full Text] [Related]
33. Interaction between opioid agonists and neurotensin on thermoregulation in the rat. I. Body temperature.
Handler CM; Mondgock DJ; Zhao SF; Geller EB; Adler MW
J Pharmacol Exp Ther; 1995 Jul; 274(1):284-92. PubMed ID: 7616410
[TBL] [Abstract][Full Text] [Related]
34. Effects of morphine, buprenorphine, pentazocine and nalorphine on acquisition and extinction of active avoidance responses in rats.
Saha N; Datta H; Sharma PL
Indian J Physiol Pharmacol; 1990 Jul; 34(3):179-82. PubMed ID: 2286420
[TBL] [Abstract][Full Text] [Related]
35. Opiates and thermoregulation in mice. I. Agonists.
Rosow CE; Miller JM; Pelikan EW; Cochin J
J Pharmacol Exp Ther; 1980 May; 213(2):273-83. PubMed ID: 6154139
[TBL] [Abstract][Full Text] [Related]
36. Some of the effects of the selective sigma ligand (+)pentazocine are mediated via a naloxone-sensitive receptor.
Couture S; Debonnel G
Synapse; 2001 Mar; 39(4):323-31. PubMed ID: 11169783
[TBL] [Abstract][Full Text] [Related]
37. Mu opioid agonists potentiate amphetamine- and cocaine-induced rotational behavior in the rat.
Kimmel HL; Holtzman SG
J Pharmacol Exp Ther; 1997 Aug; 282(2):734-46. PubMed ID: 9262337
[TBL] [Abstract][Full Text] [Related]
38. Precipitated withdrawal by pentazocine in methadone-maintained volunteers.
Strain EC; Preston KL; Liebson IA; Bigelow GE
J Pharmacol Exp Ther; 1993 Nov; 267(2):624-34. PubMed ID: 7504098
[TBL] [Abstract][Full Text] [Related]
39. Discriminative stimulus properties of (+)- and (-)-n allylnormetazocine: the role of training dose in the stimulus substitution patterns produced by PCP/sigma and mixed action opioid compounds.
Picker MJ
Behav Pharmacol; 1991 Dec; 2(6):497-511. PubMed ID: 11224092
[TBL] [Abstract][Full Text] [Related]
40. Discriminative-stimulus effects of the low efficacy mu agonist nalbuphine.
Walker EA; Young AM
J Pharmacol Exp Ther; 1993 Oct; 267(1):322-30. PubMed ID: 8229759
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
